Skip to main content
. 2019 Feb 11;6:85–90. doi: 10.1016/j.ejro.2019.02.003

Table 1.

Follow-up of 243 baseline IPN (group A).

Metastasis (%) 2 / 243 (1)
Stable (%) 48 / 243 (19)
Decreased in volume > 15% (%) 83 / 243 (34)
Initially increased and later decreased or resolved (%) 94 / 243 (39)
Resolved (%) 17 / 243 (7)
Median time to resolution - months (range) 7 (3–21)